Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genomic Approach Identifies Food Pathogens

By LabMedica International staff writers
Posted on 10 Nov 2011
A molecular approach will enable government agencies and public health officials to pinpoint the exact nature and origin of food-borne bacteria with unprecedented accuracy.

The molecular technique is able to discriminate rapidly between outbreak-related cases and non-outbreak related cases by isolating pathogens believed to be connected to contaminated food. More...


A collaborative team led by scientists at Cornell University (Ithaca, NY, USA) adopted a genomic approach to identifying food-borne pathogens. They sequenced the genome of 47 samples of the bacteria, 20 that had been collected from human sources during an outbreak, and 27 control samples collected from human, food, animal and environmental sources before the outbreak.

The team developed the single nucleotide polymorphism (SNP) test that is specific to the Salmonella enterica strain that had caused a previous outbreak. The sequencing was performed on the SOLiD systems (Life Technologies, Foster City, CA). Pulsed Field Gel Electrophoresis (PFGE) was also performed. Overall, 969 SNP positions were found among the 82 isolates analyzed.

Three SNPs were found to be completely specific for the isolates associated with the outbreak clade.

This study demonstrates that massively parallel sequencing can be used to assess the population structure of highly clonal, outbreak-associated pathogens at single base resolution. Martin Wiedmann, DVM, PhD, a professor at Cornell said, "The use of genome sequencing methods to investigate outbreaks of food-borne bacterial diseases is relatively new, and holds great promise as it can help to identify the temporal, geographical and evolutionary origin of an outbreak. In particular, full genome sequence data may help to identify small outbreaks that may not be easily detected with lower resolution subtyping approaches.” The study was published online on October 14, 2011, in the journal Applied and Environmental Microbiology.

Related Links:
Cornell University
Life Technologies




New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Collection and Transport System
PurSafe Plus®
New
Gold Member
Automated MALDI-TOF MS System
EXS 3000
New
Gold Member
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.